Skip to main content
Topics
Video
Provider
Payer
Pharma
ANZ
ASIA
EMEA
Global Edition
sexual health
Visby Medical raises up to $65M to commercialize home STI test
By
Jessica Hagen
|
11:12 am |
June 19, 2025
In March, the company received FDA marketing authorization for the first at-home test to detect chlamydia, gonorrhea and trichomoniasis.